BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.51% |
| 2 | Financials | 5.78% |
| 3 | Consumer Discretionary | 5.73% |
| 4 | Healthcare | 5.19% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKCA
3326
DELISTED
Akcea Therapeutics Inc
AKCA
| $46.7K | ﹤0.01% |
1,991
-1,174
| -37% | -$29K |
|
|
OPB
3327
DELISTED
Opus Bank Common Stock
OPB
| $46.7K | ﹤0.01% |
2,211
-1,928
| -47% | -$40.6K |
|
|
UMH
3328
UMH Properties
UMH
$1.42B
| $46.5K | ﹤0.01% |
3,748
-3,170
| -46% | -$42.7K |
|
3329
Metropolitan Bank Holding Corp
MCB
$1.17B
| $46.5K | ﹤0.01% |
1,057
-301
| -22% | -$12K |
|
3330
BioCryst Pharmaceuticals
BCRX
$2.51B
| $46.5K | ﹤0.01% |
12,261
-10,450
| -46% | -$62.9K |
|
3331
Park-Ohio Holdings
PKOH
$718M
| $46.4K | ﹤0.01% |
1,424
-448
| -24% | -$15.2K |
|
3332
Mistras Group
MG
$584M
| $46.4K | ﹤0.01% |
3,228
-854
| -21% | -$11.7K |
|
3333
CRA International
CRAI
$1.07B
| $46.4K | ﹤0.01% |
1,210
-435
| -26% | -$18.8K |
|
3334
Greif Class B
GEF.B
$4.22B
| $46.4K | ﹤0.01% |
1,062
-244
| -19% | -$11.2K |
|
3335
REX American Resources
REX
$1.44B
| $46.3K | ﹤0.01% |
3,810
-3,234
| -46% | -$42.3K |
|
3336
Greenlight Captial
GLRE
$512M
| $46.2K | ﹤0.01% |
5,446
-1,226
| -18% | -$12.6K |
|
|
FLXN
3337
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $46.2K | ﹤0.01% |
3,759
-3,234
| -46% | -$37.3K |
|
|
DS
3338
DELISTED
Drive Shack Inc.
DS
| $46.1K | ﹤0.01% |
9,824
-2,801
| -22% | -$13.6K |
|
|
ACOR
3339
DELISTED
Acorda Therapeutics
ACOR
| $46K | ﹤0.01% |
50
-35
| -41% | -$43K |
|
3340
Assembly Biosciences
ASMB
$594M
| $45.8K | ﹤0.01% |
283
-81
| -22% | -$15.4K |
|
|
AT
3341
DELISTED
Atlantic Power Corporation
AT
| $45.8K | ﹤0.01% |
18,908
-4,536
| -19% | -$10.8K |
|
3342
Ceco Environmental
CECO
$4.5B
| $45.8K | ﹤0.01% |
4,771
-1,566
| -25% | -$13.4K |
|
3343
SEACOR Marine Holdings
SMHI
$262M
| $45.7K | ﹤0.01% |
3,058
-399
| -12% | -$5.5K |
|
3344
Camping World
CWH
$675M
| $45.7K | ﹤0.01% |
3,683
-3,091
| -46% | -$39.9K |
|
|
AFI
3345
DELISTED
Armstrong Flooring, Inc.
AFI
| $45.7K | ﹤0.01% |
4,635
-234
| -5% | -$2.9K |
|
|
EIGI
3346
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $45.4K | ﹤0.01% |
9,461
-7,039
| -43% | -$38.2K |
|
|
WOW
3347
DELISTED
WideOpenWest
WOW
| $45.4K | ﹤0.01% |
6,255
-710
| -10% | -$5.78K |
|
|
CBIO
3348
Crescent Biopharma
CBIO
$618M
| $45.4K | ﹤0.01% |
38
-33
| -46% | -$39.5K |
|
3349
Turning Point Brands
TPB
$1.73B
| $45.3K | ﹤0.01% |
924
-758
| -45% | -$36.5K |
|
3350
Daily Journal
DJCO
$828M
| $45.2K | ﹤0.01% |
190
-54
| -22% | -$11.9K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.